<DOC>
	<DOCNO>NCT01882231</DOCNO>
	<brief_summary>The objective study use change 3 Tesla MRI measurement tumor protein content , cell density , microvessel perfusion , obtain single cycle NAC , predict eventual tumor response observe conclusion NAC , within patient osteosarcoma Ewing Sarcoma .</brief_summary>
	<brief_title>Quantitative Imaging Biomarkers Treatment Response Osteosarcoma Ewing Sarcoma</brief_title>
	<detailed_description>Neoadjuvant chemotherapy ( NAC ) osteosarcoma ( OS ) Ewing sarcoma ( ES ) associate significant immediate long-term complication , particularly difficult endure adolescent patient . Tumor response assess resection , often patient receive month potentially toxic ineffective therapy . Surgical approach set extensive life changing , amputation uncommon . Poor response NAC single important prognostic indicator localize OS/ES . Early identification patient unlikely benefit prescribed regimen could significant clinical implication allow early adjustment patient 's therapy . In patient OS/ES remain compelling yet unmet need advance quantitative , noninvasive imaging method deploy early initiation treatment capable longitudinally measure quantitative change relevant physiological , metabolic and/or biophysical parameter serve reliable surrogate , even predictor , long-term tumor response intervention , include pathological response surgery . In pilot study use multi-parametric 3 Tesla ( 3T ) MRI , deploy first cycle NAC , correlate early change image biomarkers patient 's eventual histopathological response surgical resection . We measure treatment-induced change : 1 ) protein content , measure via amide proton transfer asymmetry ( APTasym ) use chemical exchange saturation transfer ( CEST ) MRI ) ; 2 ) tumor fibrosis , measure via magnetization transfer ratio ( MTR ) use magnetization transfer ( MT ) MRI ) ; 3 ) tumor cellularity , measure via apparent diffusion coefficient ( ADC ) use diffusion-weighted MRI ) ; 4 ) tumor perfusion , measure via volume transfer coefficient ( Ktrans ) use dynamic contrast-enhanced DCE-MRI . The relevance future clinical impact image biomarkers ( alone combination ) OS/ES potentially high .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<criteria>Subjects must 13 year age old . Subjects ( parent legal guardian ) must sign Internal Review Board ( IRB ) approve assent/informed consent documentation . Subjects must histologically prove osteogenic sarcoma , malignant fibrous histiocytoma ( MFH ) , Ewing sarcoma . Subjects must plan resection ( include localize resectable disease patient metastatic disease plan palliative resection ) schedule begin neoadjuvant chemotherapy Subjects 13 year age . Subjects type bioimplant activate mechanical , electronic , magnetic mean ( e.g. , cochlear implant , pacemaker , neurostimulators , biostimulators , electronic infusion pump , etc ) , device may displace malfunction . Subjects type ferromagnetic bioimplant could potentially displace . Subjects cerebral aneurysm clip . Subjects may shrapnel imbedded body ( war wound ) , metal worker machinist ( potential metallic fragment near eye ) . Subjects inadequate renal function ( creatinine ≥1.5 time upper limit normal ) acute chronic renal insufficiency ( estimate glomerular filtration rate &lt; 30 mL/min ) . Subjects pregnant breast feeding , effect high field MRI fetuses yet know . Urine pregnancy test/or serum human chorionic gonadotropin ( HCG ) also perform woman child bear potential . Subjects exhibit past allergic adverse reaction response intravenous injection Magnevist® ( gadopentetate dimeglumine ) gadoliniumcontaining contrast agent . Subjects exhibit noticeable anxiety and/or claustrophobia exhibit severe vertigo move magnet bore . Subjects incapable give informed write consent , follow reason : Inability adhere experimental protocol reason Inability communicate research team Limited ability give inform consent due mental disability , alter mental status , confusion , psychiatric disorder Prisoners individual deem susceptible coercion</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Osteosarcoma</keyword>
	<keyword>Ewing sarcoma</keyword>
	<keyword>Paget 's disease</keyword>
	<keyword>bone cancer</keyword>
	<keyword>childhood cancer</keyword>
	<keyword>DCE MRI</keyword>
	<keyword>DW MRI</keyword>
	<keyword>CEST MRI</keyword>
	<keyword>MT MRI</keyword>
</DOC>